Cost-utility and value of information analysis of tisagenlecleucel for relapsed/refractory diffuse large B-cell lymphoma in the Irish healthcare setting-Reference-Cited by-同舟云学术

Cost-utility and value of information analysis of tisagenlecleucel for relapsed/refractory diffuse large B-cell lymphoma in the Irish healthcare setting

Published:2023-01-18 Issue:1 Volume:11 Page:
ISSN:2001-6689
Container-title:Journal of Market Access & Health Policy
language:en
Short-container-title:Journal of Market Access & Health Policy

Author:

Carey Niamh¹²,Leahy Joy¹²,Trela-Larsen Lea¹²,Mc Cullagh Laura¹²,Barry Michael¹²

Affiliation:

1. National Centre for Pharmacoeconomics, Old Stone Building, St James's Hospital, Dublin, Ireland

2. Department of Pharmacology and Therapeutics, Trinity Centre for Health Sciences, Trinity College Dublin, Dublin, Ireland

Funder

other

Publisher

MDPI AG

Subject

Health Informatics,Health Policy

Link

https://www.tandfonline.com/doi/pdf/10.1080/20016689.2023.2166375

Reference49 articles.

1. Guidelines for the management of diffuse large B-cell lymphoma

2. Diffuse Large B-Cell Lymphoma

3. Long-Term Results of the R-CHOP Study in the Treatment of Elderly Patients With Diffuse Large B-Cell Lymphoma: A Study by the Groupe d'Etude des Lymphomes de l'Adulte

4. Outcome of patients with relapsed diffuse large B-cell lymphoma who fail second-line salvage regimens in the International CORAL study

5. Outcomes of diffuse large B-cell lymphoma patients relapsing after autologous stem cell transplantation: an analysis of patients included in the CORAL study

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Economic Evaluations of Chimeric Antigen Receptor T-Cell Therapies for Hematologic and Solid Malignancies: A Systematic Review;Value in Health;2024-08

2. Economic evaluation of anti-CD19 CAR T-cell pathway for large B-cell lymphomas in the real-life setting: the experience of an Italian hub center in the first three years of activity;Annals of Hematology;2024-05-02